FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |   Search Term  Advanced Search

Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe

Previous Volume 317:7-12 July 2, 1987 Number 1 Next

	Add to Personal Archive Add to Citation Manager Notify a Friend E-mail When Cited PubMed Citation

Abstract

The development of new weakness, fatigue, and pain decades after acute paralytic poliomyelitis is a recognized syndrome. We conducted a controlled study of this syndrome by analyzing clinical, electromyographic, and muscle-biopsy features in 18 patients with a history of poliomyelitis--13 reporting 1 to 20 years of new weakness and 5 without new symptoms. The patients with new weakness also reported new muscle atrophy (9 of 13) and fatigue (10 of 13), symptoms not reported by the controls. The age at the time of acute poliomyelitis, severity of poliomyelitis, residual disability, number of years since acute poliomyelitis, and age at the time of study were comparable in the weakening and control groups. Evidence of remote denervation consistent with antecedent poliomyelitis was demonstrated in all patients by electromyography or muscle biopsy or both. In addition, active denervation (as evidenced by spontaneous activity on conventional electromyography, increased jitter on single-fiber electromyography, or atrophic myofibers) was found in 12 patients in the weakening group and in all 5 controls. Immunohistochemical detection of myofibers expressing the neural-cell adhesion molecule corroborated ongoing denervation in both patient groups. When muscle data from both groups were pooled, correlations were observed between the extent of past reinnervation and the degree of ongoing motor-unit instability. We conclude that the extensive reinnervation of denervated muscle that occurs in paralytic poliomyelitis may be followed by late denervation of the previously reinnervated muscle fibers. Electromyographic and muscle-biopsy evidence of ongoing denervation does not distinguish between stable patients with prior paralytic poliomyelitis and those with new weakness.

This article has been cited by other articles:

• Rogalski, E., Johnson, N., Weintraub, S., Mesulam, M. (2008). Increased Frequency of Learning Disability in Patients With Primary Progressive Aphasia and Their First-Degree Relatives. Arch Neurol 65: 244-248 [Abstract] [Full Text]  
• Hebl, J. R., Horlocker, T. T., Schroeder, D. R. (2006). Neuraxial anesthesia and analgesia in patients with preexisting central nervous system disorders.. Anesth. Analg. 103: 223-228 [Abstract] [Full Text]  
• Kim, J. W., Rizzo, J. F., Lessell, S. (2005). Delayed Visual Decline in Patients With "Stable" Optic Neuropathy. Arch Ophthalmol 123: 785-788 [Abstract] [Full Text]  
• Alberca, R., Montes, E., Russell, E., Gil-Neciga, E., Mesulam, M. (2004). Left Hemicranial Hypoplasia in 2 Patients With Primary Progressive Aphasia. Arch Neurol 61: 265-268 [Abstract] [Full Text]  
• Horemans, H L D, Nollet, F, Beelen, A, Drost, G, Stegeman, D F, Zwarts, M J, Bussmann, J B J, de Visser, M, Lankhorst, G J (2003). Pyridostigmine in postpolio syndrome: no decline in fatigue and limited functional improvement. J. Neurol. Neurosurg. Psychiatry 74: 1655-1661 [Abstract] [Full Text]  
• Jubelt, B., Agre, J. C. (2000). Characteristics and Management of Postpolio Syndrome. JAMA 284: 412-414 [Full Text]  
• Dalakas, M. C. (1999). Why drugs fail in postpolio syndrome. Neurology 53: 1166-1166 [Full Text]  
• Trojan, D. A., Collet, J.-P., Shapiro, S., Jubelt, B., Miller, R. G., Agre, J. C., Munsat, T. L., Hollander, D., Tandan, R., Granger, C., Robinson, A., Finch, L., Ducruet, T., Cashman, N. R. (1999). A multicenter, randomized, double-blinded trial of pyridostigmine in postpolio syndrome. Neurology 53: 1225-1225 [Abstract] [Full Text]  
• Ono, A., Kuwajima, M., Kono, N., Mineo, I., Nakagawa, C., Tarui, S., Matsuzawa, Y. (1995). Glucose infusion paradoxically accelerates degradation of adenine nucleotide in working muscle of patients with glycogen storage disease type VII. Neurology 45: 161-164 [Abstract] [Full Text]